As of 2026-09-13, the EV/EBITDA ratio of Profound Medical Corp (PRN.TO) is -6.25. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. PRN.TO's latest enterprise value is 234.31 mil CAD. PRN.TO's TTM EBITDA according to its financial statements is -37.47 mil CAD. Dividing these 2 quantities gives us the above PRN.TO EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 7.9x - 18.7x | 13.3x |
| Forward P/E multiples | 16.6x - 20.9x | 18.8x |
| Fair Price | (22.07) - (25.06) | (21.22) |
| Upside | -369.2% - -405.6% | -358.8% |
| Date | EV/EBITDA |
| 2026-09-04 | -5.43 |
| 2026-09-03 | -5.36 |
| 2026-09-02 | -5.36 |
| 2026-09-01 | -5.37 |
| 2026-08-31 | -5.37 |
| 2026-08-28 | -5.40 |
| 2026-08-27 | -5.50 |
| 2026-08-26 | -5.68 |
| 2026-08-25 | -5.35 |
| 2026-08-24 | -5.39 |
| 2026-08-21 | -5.28 |
| 2026-08-20 | -5.13 |
| 2026-08-19 | -5.58 |
| 2026-08-18 | -5.59 |
| 2026-08-17 | -5.20 |
| 2026-08-14 | -5.20 |
| 2026-08-13 | -5.31 |
| 2026-08-12 | -5.56 |
| 2026-08-11 | -5.57 |
| 2026-08-10 | -5.89 |
| 2026-08-07 | -5.96 |
| 2026-08-06 | -6.52 |
| 2026-08-05 | -6.60 |
| 2026-08-04 | -6.98 |
| 2026-07-31 | -6.02 |
| 2026-07-30 | -5.93 |
| 2026-07-29 | -5.92 |
| 2026-07-28 | -5.94 |
| 2026-07-27 | -6.06 |
| 2026-07-24 | -5.95 |
| 2026-07-23 | -5.52 |
| 2026-07-22 | -5.66 |
| 2026-07-21 | -5.63 |
| 2026-07-20 | -5.47 |
| 2026-07-17 | -5.47 |
| 2026-07-16 | -5.43 |
| 2026-07-15 | -5.64 |
| 2026-07-14 | -5.74 |
| 2026-07-13 | -5.87 |
| 2026-07-10 | -5.79 |
| 2026-07-09 | -6.09 |
| 2026-07-08 | -6.23 |
| 2026-07-07 | -6.16 |
| 2026-07-06 | -6.07 |
| 2026-07-03 | -5.58 |
| 2026-07-02 | -5.58 |
| 2026-06-30 | -5.36 |
| 2026-06-29 | -5.33 |
| 2026-06-26 | -5.29 |
| 2026-06-25 | -5.02 |